Speak with your healthcare provider if any of these apply to you: History of pancreatitis Thyroid tumour history Severe kidney concerns Type 1 diabetes History of eating disorders Pregnant or breastfeeding Under 18 years of age Known peptide allergies The following events were uncommon in research and typically resolved without intervention: Gallstone formation: Infrequent, comparable to other GLP-1 class medications Dysesthesia (tingling/numbness): Mild and temporary in most cases, linked to glucagon receptor activity Injection site reactions: Minor redness or swelling at the injection site, resolving quickly Protect from light Avoid freeze-thaw cycling Refrigerate after reconstitution 20C Lyophilized Long-term 28C Reconstituted ~30 days Common questions about Retatrutide 50mg research and therapy Retatrutide 50mg is a synthetic peptide that simultaneously activates three hormone receptors: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and the glucagon receptor
.png)
Obesity is a chronic, systemic disease driven by excess adiposity that can cause severe organ dysfunction and lifethreatening complications (for example, stroke, cardiovascular disease, type 2 diabetes, depression, and certain cancers) [1,2]
Gonadotropins Increased GH and IGF1 levels can influence gonadotropin secretion
How long does it take to administer